WHO ICTRP trial
The efficacy and safety in canaglifrozin therapy for diabetes complicated by…
JPRN-UMIN000023044 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000023044 |
|---|---|
| Public title | The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease. |
| Scientific title | The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease. - The efficacy of Canaglifrozin for NAFLD. |
| Primary sponsor | Kyoto prefetural University of Medicine |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Nonalcoholic fatty liver disease type 2 diabetes mellitus |
| Interventions | canaglifrozin 100mg for 12 weeks |
| Registration date | Oct 21, 2016 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: